Omnitrope 45IU (15mg) is a somatropin product containing recombinant human growth hormone. The 15 mg/1.5 ml cartridge corresponds to 45 IU of somatropin, and official product information identifies Sandoz as the marketing-authorisation holder.

The product is intended for medically diagnosed growth hormone deficiency and certain other approved conditions in children and adults. It is a prescription medicine, so its use should be determined and monitored by an appropriately qualified healthcare professional.

According to the Apotheka product page, the listing describes Omnitrope 45IU (15mg) as in stock, with a package containing one vial and Sandoz, Turkey listed as the manufacturer. However, the listing itself should not be treated as evidence of authenticity, therapeutic effectiveness, or suitability for an individual.

One notable point is that official documentation describes the 15 mg presentation as a clear, colourless injectable solution intended for use with the appropriate SurePal 15 device. Proper storage is also important; official product information specifies refrigerated storage at 2–8°C and advises against freezing.

Overall, Omnitrope is an established somatropin medicine with clearly documented composition and approved medical uses. Anyone considering this product should verify its authenticity, prescription status, storage conditions, and suitability with a healthcare professional rather than relying solely on an online product listing.